Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

par Brubaker, Kristen D, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publié 2006

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

par Morrissey, Colm, Kostenuik, Paul L, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publié 2007

Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment

par Morrissey, Colm, Brown, Lisha G, Pitts, Tiffany EM, Vessella, Robert L, Corey, Eva
Publié 2010

Nemo-Like Kinase Induces Apoptosis and Inhibits Androgen Receptor Signaling in Prostate Cancer Cells

par Emami, Katayoon H., Brown, Lisha G., Pitts, Tiffany E.M., Sun, Xizhang, Vessella, Robert L., Corey, Eva
Publié 2009

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone

par Kirk, Peter S., Koreckij, Theodore, Nguyen, Holly M., Brown, Lisha G., Snyder, Linda A., Vessella, Robert L., Corey, Eva
Publié 2013

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature

par Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Nguyen, Holly M., Lin, Daniel W., Corey, Eva, Nelson, Peter S., Morrissey, Colm
Publié dans PLoS One (2021)

Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes

par Coleman, Ilsa M, Kiefer, Jeffrey A, Brown, Lisha G, Pitts, Tiffany E, Nelson, Peter S, Brubaker, Kristen D, Vessella, Robert L, Corey, Eva
Publié 2006

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

par Nguyen, Holly M., Ruppender, Nazanin, Zhang, Xiaotun, Brown, Lisha G., Gross, Ted S., Morrissey, Colm, Gulati, Roman, Vessella, Robert L., Schimmoller, Frauke, Aftab, Dana T., Corey, Eva
Publié 2013

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

par Larson, Sandy R., Chin, Jessica, Zhang, Xiaotun, Brown, Lisha G., Coleman, Ilsa M., Lakely, Bryce, Tenniswood, Martin, Corey, Eva, Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publié 2013

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer

par Wu, Yu, Schoenborn, Jamie R., Morrissey, Colm, Xia, Jing, Larson, Sandy, Brown, Lisha G., Qu, Xiaoyu, Lange, Paul H., Nelson, Peter S., Vessella, Robert L., Fang, Min
Publié dans J Mol Diagn (2016)

The Expression of Osteoclastogenesis-Associated Factors and Osteoblast Response to Osteolytic Prostate Cancer Cells

par Morrissey, Colm, Lai, Janice S., Brown, Lisha G., Wang, Ya-Chun, Roudier, Martine P., Coleman, Ilsa M., Gulati, Roman, Vakar-Lopez, Funda, True, Lawrence D., Eva, Corey, Nelson, Peter S., Vessella, Robert L.
Publié 2010

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an­­d Serve as Models for Evaluating Cancer Therapeutics

par Nguyen, Holly M., Vessella, Robert L., Morrissey, Colm, Brown, Lisha G., Coleman, Ilsa M., Higano, Celestia S., Mostaghel, Elahe A., Zhang, Xiaotun, True, Lawrence D., Lam, Hung‐Ming, Roudier, Martine, Lange, Paul H., Nelson, Peter S., Corey, Eva
Publié dans Prostate (2017)

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response...

par Lam, Hung-Ming, Nguyen, Holly M., Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Gulati, Roman, Lakely, Bryce, Sondheim, Daniel, Chatterjee, Payel, Marck, Brett T., Matsumoto, Alvin M., Mostaghel, Elahe A., Schweizer, Michael T., Nelson, Peter S., Corey, Eva
Publié dans Eur Urol (2019)

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

par Lam, Hung-Ming, McMullin, Ryan, Nguyen, Holly M., Coleman, Ilsa, Gormley, Michael, Gulati, Roman, Brown, Lisha G., Holt, Sarah K., Li, Weimin, Ricci, Deborah S., Verstraeten, Karin, Thomas, Shibu, Mostaghel, Elahe A., Nelson, Peter S., Vessella, Robert L., Corey, Eva
Publié dans Clin Cancer Res (2016)

Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

par Corella, Alexandra N., Ordonio, Ma Victoria Andrea Cabiliza, Coleman, Ilsa, Lucas, Jared M., Kaipainen, Arja, Nguyen, Holly M., Sondheim, Daniel, Brown, Lisha G., True, Lawrence, Lee, John, MacPherson, David, Nghiem, Paul, Gulati, Roman, Morrissey, Colm, Corey, Eva, Nelson, Peter S.
Publié dans Clin Cancer Res (2019)

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

par Zhang, Xiaotun, Coleman, Ilsa M., Brown, Lisha G., True, Lawrence D., Kollath, Lori, Lucas, Jared M., Lam, Hung-Ming, Dumpit, Ruth, Corey, Eva, Chéry, Lisly, Lakely, Bryce, Higano, Celestia S., Montgomery, Bruce, Roudier, Martine, Lange, Paul H., Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publié dans Clin Cancer Res (2015)

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

par Haider, Maahum, Zhang, Xiaotun, Coleman, Ilsa, Ericson, Nolan, True, Lawrence D., Lam, Hung-Ming, Brown, Lisha G., Ketchanji, Melanie, Nghiem, Belinda, Lakely, Bryce, Coleman, Roger, Montgomery, Bruce, Lange, Paul H., Roudier, Martine, Higano, Celestia S., Bielas, Jason H., Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publié dans Clin Exp Metastasis (2015)

Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer

par Kumar, Akash, Coleman, Ilsa, Morrissey, Colm, Zhang, Xiaotun, True, Lawrence D., Gulati, Roman, Etzioni, Ruth, Bolouri, Hamid, Montgomery, Bruce, White, Thomas, Lucas, Jared M., Brown, Lisha G., Dumpit, Ruth F., DeSarkar, Navonil, Higano, Celestia, Yu, Evan Y., Coleman, Roger, Schultz, Nikolaus, Fang, Min, Lange, Paul H., Shendure, Jay, Vessella, Robert L., Nelson, Peter S.
Publié dans Nat Med (2016)

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

par Labrecque, Mark P., Coleman, Ilsa M., Brown, Lisha G., True, Lawrence D., Kollath, Lori, Lakely, Bryce, Nguyen, Holly M., Yang, Yu C., da Costa, Rui M. Gil, Kaipainen, Arja, Coleman, Roger, Higano, Celestia S., Yu, Evan Y., Cheng, Heather H., Mostaghel, Elahe A., Montgomery, Bruce, Schweizer, Michael T., Hsieh, Andrew C., Lin, Daniel W., Corey, Eva, Nelson, Peter S., Morrissey, Colm
Publié dans J Clin Invest (2019)

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

par Bluemn, Eric G., Coleman, Ilsa M., Lucas, Jared M., Coleman, Roger T., Hernandez-Lopez, Susana, Tharakan, Robin, Bianchi-Frias, Daniella, Dumpit, Ruth F., Kaipainen, Arja, Corella, Alexandra N., Yang, Yu Chi, Nyquist, Michael D., Mostaghel, Elahe, Hsieh, Andrew C., Zhang, Xiaotun, Corey, Eva, Brown, Lisha G., Nguyen, Holly M., Pienta, Kenneth, Ittmann, Michael, Schweizer, Michael, True, Lawrence D., Wise, David, Rennie, Paul S., Vessella, Robert L., Morrissey, Colm, Nelson, Peter S.
Publié dans Cancer Cell (2017)